vs
First Bancorp, Inc（FNLC）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
First Bancorp, Inc的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.8M vs $19.6M），First Bancorp, Inc净利率更高（39.4% vs -177.4%，领先216.8%），First Bancorp, Inc同比增速更快（17.5% vs -11.5%），First Bancorp, Inc自由现金流更多（$34.6M vs $-23.1M），过去两年First Bancorp, Inc的营收复合增速更高（18.1% vs -12.2%）
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FNLC vs LAB — 直观对比
营收规模更大
FNLC
是对方的1.3倍
$19.6M
营收增速更快
FNLC
高出29.0%
-11.5%
净利率更高
FNLC
高出216.8%
-177.4%
自由现金流更多
FNLC
多$57.7M
$-23.1M
两年增速更快
FNLC
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $19.6M |
| 净利润 | $10.2M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 48.1% | -168.5% |
| 净利率 | 39.4% | -177.4% |
| 营收同比 | 17.5% | -11.5% |
| 净利润同比 | 39.7% | -28.8% |
| 每股收益（稀释后） | $0.91 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNLCLAB
| Q4 25 | $25.8M | — | ||
| Q3 25 | $24.5M | $19.6M | ||
| Q2 25 | $22.5M | $21.8M | ||
| Q1 25 | $21.8M | $40.8M | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $20.5M | $22.1M | ||
| Q2 24 | $19.2M | $22.5M | ||
| Q1 24 | $18.5M | $45.5M |
净利润FNLCLAB
| Q4 25 | $10.2M | — | ||
| Q3 25 | $9.1M | $-34.7M | ||
| Q2 25 | $8.1M | $-33.5M | ||
| Q1 25 | $7.1M | $-26.0M | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $7.6M | $-26.9M | ||
| Q2 24 | $6.2M | $-45.7M | ||
| Q1 24 | $6.0M | $-32.2M |
毛利率FNLCLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率FNLCLAB
| Q4 25 | 48.1% | — | ||
| Q3 25 | 45.2% | -168.5% | ||
| Q2 25 | 43.7% | -118.1% | ||
| Q1 25 | 39.3% | -80.8% | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 44.6% | -120.9% | ||
| Q2 24 | 38.8% | -134.5% | ||
| Q1 24 | 39.3% | -132.2% |
净利率FNLCLAB
| Q4 25 | 39.4% | — | ||
| Q3 25 | 37.0% | -177.4% | ||
| Q2 25 | 35.8% | -153.7% | ||
| Q1 25 | 32.5% | -63.8% | ||
| Q4 24 | 33.1% | — | ||
| Q3 24 | 36.9% | -122.0% | ||
| Q2 24 | 32.1% | -203.3% | ||
| Q1 24 | 32.5% | -70.6% |
每股收益（稀释后）FNLCLAB
| Q4 25 | $0.91 | — | ||
| Q3 25 | $0.81 | $-0.09 | ||
| Q2 25 | $0.72 | $-0.09 | ||
| Q1 25 | $0.63 | $-0.07 | ||
| Q4 24 | $0.66 | — | ||
| Q3 24 | $0.68 | $-0.07 | ||
| Q2 24 | $0.55 | $-0.12 | ||
| Q1 24 | $0.54 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | $95.5M | — |
| 股东权益账面价值 | $283.1M | $399.7M |
| 总资产 | $3.2B | $539.6M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资FNLCLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务FNLCLAB
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | $55.2M | ||
| Q2 24 | $70.0M | $55.1M | ||
| Q1 24 | $70.0M | $55.0M |
股东权益FNLCLAB
| Q4 25 | $283.1M | — | ||
| Q3 25 | $274.6M | $399.7M | ||
| Q2 25 | $265.5M | $424.5M | ||
| Q1 25 | $259.7M | $454.6M | ||
| Q4 24 | $252.5M | — | ||
| Q3 24 | $256.8M | $489.3M | ||
| Q2 24 | $244.7M | $510.3M | ||
| Q1 24 | $242.6M | $577.3M |
总资产FNLCLAB
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | $539.6M | ||
| Q2 25 | $3.2B | $557.0M | ||
| Q1 25 | $3.2B | $579.6M | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.1B | $681.5M | ||
| Q2 24 | $3.1B | $708.7M | ||
| Q1 24 | $3.0B | $777.7M |
负债/权益比FNLCLAB
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | 0.11× | ||
| Q2 24 | 0.29× | 0.11× | ||
| Q1 24 | 0.29× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | 133.9% | -118.1% |
| 资本支出强度资本支出/营收 | 12.5% | 4.5% |
| 现金转化率经营现金流/净利润 | 3.72× | — |
| 过去12个月自由现金流最近4个季度 | $55.3M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FNLCLAB
| Q4 25 | $37.8M | — | ||
| Q3 25 | $12.9M | $-22.2M | ||
| Q2 25 | $7.4M | $-20.7M | ||
| Q1 25 | $2.2M | $-30.3M | ||
| Q4 24 | $26.0M | — | ||
| Q3 24 | $9.8M | $-27.9M | ||
| Q2 24 | $6.4M | $-39.0M | ||
| Q1 24 | $-1.5M | $-62.5M |
自由现金流FNLCLAB
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | $-23.1M | ||
| Q2 25 | $7.2M | $-22.6M | ||
| Q1 25 | $828.0K | $-35.3M | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $9.6M | $-30.1M | ||
| Q2 24 | $6.3M | $-41.0M | ||
| Q1 24 | $-1.8M | $-63.3M |
自由现金流率FNLCLAB
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | -118.1% | ||
| Q2 25 | 32.1% | -103.6% | ||
| Q1 25 | 3.8% | -86.6% | ||
| Q4 24 | 111.7% | — | ||
| Q3 24 | 47.0% | -136.4% | ||
| Q2 24 | 32.9% | -182.2% | ||
| Q1 24 | -9.8% | -138.9% |
资本支出强度FNLCLAB
| Q4 25 | 12.5% | — | ||
| Q3 25 | 1.2% | 4.5% | ||
| Q2 25 | 0.6% | 8.7% | ||
| Q1 25 | 6.2% | 12.4% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 0.5% | 10.2% | ||
| Q2 24 | 0.3% | 8.6% | ||
| Q1 24 | 1.8% | 1.7% |
现金转化率FNLCLAB
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FNLC
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
